Sarah B. Noonberg - 18 Jun 2024 Form 4 Insider Report for MARINUS PHARMACEUTICALS, INC. (MRNS)

Role
Director
Signature
/s/ Debra A. Mohollen, Attorney-in-Fact
Issuer symbol
MRNS
Transactions as of
18 Jun 2024
Net transactions value
$0
Form type
4
Filing time
20 Jun 2024, 16:27:11 UTC
Previous filing
17 Jun 2024
Next filing
03 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNS Common Stock Award $0 +2,300 +19% $0.000000 14,100 18 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNS Stock Option (Right to Buy) Award $0 +10,450 $0.000000 10,450 18 Jun 2024 Common Stock 10,450 $1.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
F2 The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer.